CD95 ligand expression mediates immune escape in breast cancer

被引：0
|
作者：
C Moers
M Müschen
MW Beckmann
P Mallmann
机构：
[1] Klinik für Geburtshilfe und Gynäkologie,Klinik für Geburtshilfe und Gynäkologie
[2] Klinik für Genetik,undefined
[3] Universität zu Köln,undefined
[4] Universität Erlangen,undefined
来源：
Breast Cancer Research | / 3卷 / Suppl 1期
关键词：
Breast Cancer; Cancer Patient; Breast Cancer Cell; Breast Cancer Patient; Culture Supernatant;
D O I：
10.1186/bcr406
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Synergy of CD95 ligand and teniposide: No role of cleavable complex formation and enhanced CD95 expression
    Winter, S
    Roth, W
    Dichgans, J
    Weller, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 341 (2-3) : 323 - 328
  • [22] Characterisation of the roles of CD95 and CD95 ligand in cord blood
    Drénou, B
    Choqueux, C
    El Ghalbzouri, A
    Blancheteau, V
    Toubert, A
    Charron, D
    Mooney, N
    BONE MARROW TRANSPLANTATION, 1998, 22 : S44 - S47
  • [23] Expression of fas (CD95/APO-1) ligand by human breast cancers: Significance for tumor immune privilege
    O'Connell, J
    Bennett, MW
    O'Sullivan, GC
    O'Callaghan, J
    Collins, JK
    Shanahan, F
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (04) : 457 - 463
  • [24] Differential and mutually exclusive expression of CD95 and CD95 ligand in epithelia of normal pancreas and chronic pancreatitis
    Hasel, C
    Rau, B
    Perner, S
    Sträter, J
    Möller, P
    LABORATORY INVESTIGATION, 2001, 81 (03) : 317 - 326
  • [25] Regulation of CD95 (Fas) ligand expression in activated T cells and immune privileged tissues
    Latinis, KM
    Norian, LA
    Koretzky, GA
    FASEB JOURNAL, 1998, 12 (05): : A932 - A932
  • [26] The death of a T-cell: expression of the CD95 ligand
    Li-Weber, M
    Krammer, PH
    CELL DEATH AND DIFFERENTIATION, 2002, 9 (02): : 101 - 103
  • [27] The death of a T-cell: expression of the CD95 ligand
    M Li-Weber
    P H Krammer
    Cell Death & Differentiation, 2002, 9 : 101 - 103
  • [28] CD95 ligand expression on alpha cells: protection or killing?
    Ruberti, G
    Signore, A
    DIABETES-METABOLISM REVIEWS, 1998, 14 (02): : 191 - 192
  • [29] Expression of CD95 ligand in melanocytic lesions as a diagnostic marker
    Maeda, A
    Aragane, Y
    Tezuka, T
    BRITISH JOURNAL OF DERMATOLOGY, 1998, 139 (02) : 198 - 206
  • [30] Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma
    Glick, RD
    Swendeman, SL
    Coffey, DC
    Rifkind, RA
    Marks, PA
    Richon, VM
    La Quaglia, MP
    CANCER RESEARCH, 1999, 59 (17) : 4392 - 4399
12345